These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Intraglomerular coagulation and fibrinolysis in human primary glomerular diseases]. Shibata K; Dohi K; Fujii Y; Ishikawa H Nihon Jinzo Gakkai Shi; 1991 Aug; 33(8):719-29. PubMed ID: 1770632 [TBL] [Abstract][Full Text] [Related]
7. The involvement of plasmatic and fibrinolytic systems in idiopathic glomerulonephritis (GN). Andrassy K; Ritz E; Waldherr R Adv Exp Med Biol; 1984; 167():273-85. PubMed ID: 6711378 [No Abstract] [Full Text] [Related]
8. Urinary fibrin-fibrinogen degradation products in nephrotic syndrome. Hall CL; Pejhan N; Terry JM; Blainey JD Br Med J; 1975 Feb; 1(5955):419-22. PubMed ID: 803853 [TBL] [Abstract][Full Text] [Related]
9. [Role of fibrinolytic activity in renal pathology]. Kacprzyk F Pol Tyg Lek; 1975 Aug; 30(34):1409-11. PubMed ID: 1099553 [No Abstract] [Full Text] [Related]
11. Characterization and significance of urinary fibrin degradation products. Cortes P; Potter EV; Kwaan HC J Lab Clin Med; 1973 Sep; 82(3):377-89. PubMed ID: 4199524 [No Abstract] [Full Text] [Related]
12. Study of the correlation between glomerular and urinary sediment deposits using immunofluorescent technique. Orfila C; Mignon-Conte M; De Boissezon JF; Suc JM Biomedicine; 1977 Mar; 27(2):89-92. PubMed ID: 324533 [TBL] [Abstract][Full Text] [Related]
13. Fibrinolysis in glomerulonephritis treated with ancrod: renal functional, immunologic and histopathologic effects. Kim S; Wadhwa NK; Kant KS; Pollak VE; Glas-Greenwalt P; Weiss MA; Hong CG Q J Med; 1988 Nov; 69(259):879-905. PubMed ID: 3078212 [TBL] [Abstract][Full Text] [Related]
15. Fibrin/fibrinogen degradation products in glomerulonephritis. Yatzidis H Br Med J; 1971 Sep; 3(5777):767. PubMed ID: 5097978 [No Abstract] [Full Text] [Related]
16. [Clinical importance of determination of the products of decomposition of fibrin and fibrinogen in urine in patients with glomerulonephritis]. Belitskaia GA; Ena IaM; Varetskaia TV; Tsynkalevskaia SN; Tsariuk LA Ter Arkh; 1975; 47(4):46-50. PubMed ID: 1145480 [No Abstract] [Full Text] [Related]
17. Urinary procoagulant and fibrinolytic activity in human glomerulonephritis. Relationship with renal function. Colucci M; Semeraro N; Montemurro P; Chiumarulo P; Triggiani R; Morrone LF; Schena FP Kidney Int; 1991 Jun; 39(6):1213-7. PubMed ID: 1910125 [TBL] [Abstract][Full Text] [Related]
18. Urinary fibrin-fibrinogen degradation products (FDP) in renal diseases and during thrombolytic therapy. Hedner U Scand J Clin Lab Invest; 1973 Oct; 32(2):175-82. PubMed ID: 4588514 [No Abstract] [Full Text] [Related]
19. Determination of tissue type plasminogen activator in the glomeruli of patients with IgA nephropathy. Garcia G; Miura M; Nomoto Y; Sakai H Tokai J Exp Clin Med; 1989 Apr; 14(2):131-7. PubMed ID: 2517871 [TBL] [Abstract][Full Text] [Related]
20. [Blood coagulation system and fibrinolysis in glomerulonephritis (review of the literature)]. Panchenko VM; Gilunova NI; Kozhomkulova BZh Lab Delo; 1977; (8):451-4. PubMed ID: 72846 [No Abstract] [Full Text] [Related] [Next] [New Search]